AJP - Regu Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 250: R960-R972, 1986;
0363-6119/86 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, J. E.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 250, Issue 6 960-R972, Copyright © 1986 by American Physiological Society

ARTICLES

Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation

J. E. Hall

Angiotensin II (ANG II) is one of the body's most powerful regulators of Na excretion, operating through extrarenal mechanisms, such as stimulation of aldosterone secretion, as well as intrarenal mechanisms. Considerable evidence suggests that the intrarenal actions of ANG II are quantitatively more important than changes in aldosterone secretion in the normal day-to-day regulation of Na balance and arterial pressure. ANG II at physiological concentrations increases proximal tubular reabsorption, but further studies are needed to determine whether ANG II also has an important effect on more distal tubular segments. ANG II also markedly constricts efferent arterioles, tending to increase Na reabsorption by altering peritubular capillary physical forces and also helping to prevent excessive decreases in glomerular filtration rate. ANG II may also decrease Na excretion and increase urine concentrating ability by reducing renal medullary blood flow. Regulation of Na excretion by ANG II is closely linked with arterial pressure control and volume homeostasis through the renal pressure natriuresis mechanism. Under many physiological conditions, such as changes in Na intake, ANG II greatly multiplies the effectiveness of the pressure natriuresis mechanism to prevent fluctuations in body fluid volume and arterial pressure. In circumstances associated with circulatory depression, such as decreased cardiac function, reductions in blood pressure and increased ANG II formation cause Na retention until arterial pressure is restored to normal. However, in pathophysiological conditions in which ANG II is inappropriately elevated, increased arterial pressure (hypertension) is required for the kidney to "escape" the potent antinatriuretic actions of ANG II and to return Na excretion to normal via the pressure natriuresis mechanism.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. H. Pojoga, T. M. Yao, S. Sinha, R. L. Ross, J. C. Lin, J. D. Raffetto, G. K. Adler, G. H. Williams, and R. A. Khalil
Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1258 - H1265.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. C. Chappell, L. M. Yamaleyeva, and B. M. Westwood
Estrogen and salt sensitivity in the female mRen(2).Lewis rat
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1557 - R1563.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. A. Khalil
Dietary salt and hypertension: new molecular targets add more spice
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R509 - R513.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
P. M. O'Connor, M. M. Kett, W. P. Anderson, and R. G. Evans
Renal medullary tissue oxygenation is dependent on both cortical and medullary blood flow
Am J Physiol Renal Physiol, March 1, 2006; 290(3): F688 - F694.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
N. Lerolle, S. Bourgeois, F. Leviel, G. Lebrun, M. Paillard, and P. Houillier
Angiotensin II inhibits NaCl absorption in the rat medullary thick ascending limb
Am J Physiol Renal Physiol, September 1, 2004; 287(3): F404 - F410.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
T. H. Le, M. I. Oliverio, H.-S. Kim, H. Salzler, R. C. Dash, D. N. Howell, O. Smithies, S. Bronson, and T. M. Coffman
A {gamma}GT-AT1A receptor transgene protects renal cortical structure in AT1 receptor-deficient mice
Physiol Genomics, August 11, 2004; 18(3): 290 - 298.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. Osborn, P. Ariza-Nieto, J. P. Collister, S. Soucheray, B. Zimmerman, and S. Katz
Responsiveness vs. basal activity of plasma ANG II as a determinant of arterial pressure salt sensitivity
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2142 - H2149.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. J. Mangrum, R. A. Gomez, and V. F. Norwood
Effects of AT1A receptor deletion on blood pressure and sodium excretion during altered dietary salt intake
Am J Physiol Renal Physiol, September 1, 2002; 283(3): F447 - F453.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Schou, A. Gabrielsen, N. E. Bruun, P. Skott, B. Pump, H. Dige-Petersen, E. Frandsen, P. Bie, J. Warberg, N. J. Christensen, et al.
Angiotensin II attenuates the natriuresis of water immersion in humans
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R187 - R196.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. Peti-Peterdi, D. G. Warnock, and P. D. Bell
Angiotensin II Directly Stimulates ENaC Activity in the Cortical Collecting Duct via AT1 Receptors
J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1131 - 1135.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. H. Pratt, G. J. Eckert, S. Newman, and W. T. Ambrosius
Blood Pressure Responses to Small Doses of Amiloride and Spironolactone in Normotensive Subjects
Hypertension, November 1, 2001; 38(5): 1124 - 1129.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. M. Boesch and J. L. Garvin
Age-dependent activation of PKC isoforms by angiotensin II in the proximal nephron
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R861 - R867.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
B. T. Alexander, K. Cockrell, F. D. Cline, M. T. Llinas, M. Sedeek, and J. P. Granger
Effect of Angiotensin II Synthesis Blockade on the Hypertensive Response to Chronic Reductions in Uterine Perfusion Pressure in Pregnant Rats
Hypertension, September 1, 2001; 38(3): 742 - 745.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Gabrielsen, P. Bie, N. H. Holstein-Rathlou, N. J. Christensen, J. Warberg, H. Dige-Petersen, E. Frandsen, S. Galatius, B. Pump, V. B. Sorensen, et al.
Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R459 - R467.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. T. Alexander, K. L. Cockrell, A. N. Rinewalt, J. N. Herrington, and J. P. Granger
Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1388 - R1392.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H. Peng, O. A. Carretero, M. E. Alfie, J. A. Masura, and N.-E. Rhaleb
Effects of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Type 1 Receptor Antagonist in Deoxycorticosterone Acetate-Salt Hypertensive Mice Lacking Ren-2 Gene
Hypertension, March 1, 2001; 37(3): 974 - 980.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. Simon and G. Illyes
Structural Vascular Changes in Hypertension : Role of Angiotensin II, Dietary Sodium Supplementation, and Sympathetic Stimulation, Alone and in Combination in Rats
Hypertension, February 1, 2001; 37(2): 255 - 260.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
W. Wu, Y. Zhang, J. R. Ballew, G. Fink, and D. H. Wang
Development of Hypertension Induced by Subpressor Infusion of Angiotensin II : Role of Sensory Nerves
Hypertension, October 1, 2000; 36(4): 549 - 552.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
M. I. Oliverio and T. M. Coffman
Angiotensin II Receptor Physiology Using Gene Targeting
Physiology, August 1, 2000; 15(4): 171 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. E. Steele, L. G. Koch, and P. H. Brand
State-Dependent Expression of Pressure Diuresis in Conscious Rats
Experimental Biology and Medicine, June 1, 2000; 224(2): 109 - 115.
[Abstract] [Full Text]

Home page
 HypertensionHome page
M. I. Oliverio, C. F. Best, O. Smithies, and T. M. Coffman
Regulation of Sodium Balance and Blood Pressure by the AT1A Receptor for Angiotensin II
Hypertension, February 1, 2000; 35(2): 550 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. Paradis, N. Dali-Youcef, F. W. Paradis, G. Thibault, and M. Nemer
Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling
PNAS, January 18, 2000; 97(2): 931 - 936.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
N Girgrah, P Liu, J Collier, L Blendis, and F Wong
Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis
Gut, January 1, 2000; 46(1): 114 - 120.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H. Karam, J.-P. Clozel, P. Bruneval, M.-F. Gonzalez, and J. Menard
Contrasting Effects of Selective T- and L-Type Calcium Channel Blockade on Glomerular Damage in DOCA Hypertensive Rats
Hypertension, October 1, 1999; 34(4): 673 - 678.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
F. Amiri and R. Garcia
Regulation of angiotensin II receptors and PKC isoforms by glucose in rat mesangial cells
Am J Physiol Renal Physiol, May 1, 1999; 276(5): F691 - F699.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. C. Hunt, N. R. Cook, A. Oberman, J. A. Cutler, C. H. Hennekens, P. S. Allender, W. G. Walker, P. K. Whelton, and R. R. Williams
Angiotensinogen Genotype, Sodium Reduction, Weight Loss, and Prevention of Hypertension : Trials of Hypertension Prevention, Phase II
Hypertension, September 1, 1998; 32(3): 393 - 401.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Q. Li, M. J. Sullivan, W. E. Dale, E. M. Hasser, E. H. Blaine, and J. T. Cunningham
Fos-Like Immunoreactivity in the Medulla after Acute and Chronic Angiotensin II Infusion
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1165 - 1173.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. P. Collister and J. W. Osborn
Area postrema lesion attenuates the long-term hypotensive effects of losartan in salt-replete rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R357 - R366.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. G. Melo, A. T. Veress, C. K. Chong, S. C. Pang, T. G. Flynn, and H. Sonnenberg
Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R255 - R261.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. B. Gonzalez, V. L. M. Herrera, and N. Ruiz-Opazo
Renal Immunocytochemical Distribution and Pharmacological Properties of the Dual Angiotensin II/AVP Receptor
Hypertension, April 1, 1997; 29(4): 957 - 961.
[Abstract] [Full Text]

Home page
 HypertensionHome page
H. Karam, D. Heudes, P. Bruneval, M.-F. Gonzales, B.-M. Loffler, M. Clozel, and J.-P. Clozel
Endothelin Antagonism in End-Organ Damage of Spontaneously Hypertensive Rats: Comparison With Angiotensin-Converting Enzyme Inhibition and Calcium Antagonism
Hypertension, September 1, 1996; 28(3): 379 - 385.
[Abstract] [Full Text]

Home page
 HypertensionHome page
A. Luchner, T. L. Stevens, D. D. Borgeson, M. M. Redfield, J. E. Bailey, S. M. Sandberg, D. M. Heublein, and J. C. Burnett
Angiotensin II in the Evolution of Experimental Heart Failure
Hypertension, September 1, 1996; 28(3): 472 - 477.
[Abstract] [Full Text]

Home page
 HypertensionHome page
J. P. Collister, B. J. Hornfeldt, and J. W. Osborn
Hypotensive Response to Losartan in Normal Rats : Role of Ang II and the Area Postrema
Hypertension, March 1, 1996; 27(3): 598 - 606.
[Abstract] [Full Text]

Home page
 HypertensionHome page
V. Gross, A. Lippoldt, W. Schneider, and F. C. Luft
Effect of Captopril and Angiotensin II Receptor Blockade on Pressure Natriuresis in Transgenic TGR(mRen-2)27 Rats
Hypertension, September 1, 1995; 26(3): 471 - 479.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
X. Ma, M. W. Chapleau, C. A. Whiteis, F. M. Abboud, and K. Bielefeldt
Angiotensin Selectively Activates a Subpopulation of Postganglionic Sympathetic Neurons in Mice
Circ. Res., April 27, 2001; 88(8): 787 - 793.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online